In bladder cancer, it has been found that the expression of hepaCAM is silenced by hypermethylation, and reversal of hypermethylation by inhibiting DNA methyltransferases led to the reexpression of hepaCAM and reduction in cell growth9, 10, 11. Here, HEPACAM is linked to urinary bladder cancer.